Annual Report 2013
Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.
Fourth quarter and full year results 2013
JP Morgan Healthcare Conference
Global diabetes alliance analyst call
Currency guidance 2014
In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.
The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.
Keeping investors in touch
AstraZeneca Investor Relations iPad app
The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.
Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.
Q4 2013 investor presentation
Download our interactive investor presentation to review our latest financial information, product performance and see progress on our development pipeline of potential new medicines.Investor Relations interactive presentation (PDF 14251kb)
Definition of Core Financial Measures
Definition of Core Financial Measures will change with effect from Q1 2013.
Annual information update
This update relates to information that has been published or made available to the public between 8 April 2011 and 10 April 2012.Annual information update 2012 (PDF 73kb)